Know Your Ports - Oncology Nursing News
Dec 21, 2017 · Throughout the course of treatment, many patients with cancer receive chemotherapy, intravenous fluids, antibiotics, and much more via central venous catheters such as Mediports.
Oncology Nursing News
Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in EGFR-mutated advanced non–small cell lung cancer (NSCLC), with Dr Scott highlighting its potential clinical benefits, while Squires shares insights on managing the adverse event profile and strategies for managing adverse effects in patients receiving intravenous (IV ...
20 Inspirational Quotes for Cancer Survivors, Fighters, and Caregivers
Aug 25, 2015 · The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.
Low-Dose Tamoxifen Shows Continued Efficacy in Adjuvant …
Feb 17, 2023 · Tamoxifen, at a dose of 5 mg daily (babytam), continued to show a benefit over placebo in reducing the risk of recurrence from invasive breast cancers and ductal carcinoma in situ (DCIS) in women with breast intraepithelial neoplasia in a 10-year follow-up of the TAM-01 trial (NCT01357772).
PD-L1 CPS Score Could Direct Treatment Decisions in Recurrent ...
Apr 1, 2022 · PD-L1 combined positive score (CPS) may serve to predict whether a patient with PD-L1–expressing recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) will receive optimal benefit with pembrolizumab (Keytruda) alone vs in combination with chemotherapy or with cetuximab (Erbitux) plus chemotherapy, according to an efficacy subgroup analysis of the phase 3 KEYNOTE-048 trial ...
Gifts From Patients: Accept or Reject? - Oncology Nursing News
Dec 29, 2017 · Accepting gifts can be a complex issue for all healthcare providers but especially oncology nurses, who develop a special, unique bond with patients and their families, who often want to show tangible appreciation for their care.
What Are Professional Boundaries and Why Do They Matter?
Oct 4, 2017 · Perhaps when you read the title, your first thought was, “Oh great. Someone is going to tell me what I can and cannot do in my nursing practice.”
Opinion: The Media May Have Oversold AOH1996, City of Hope's …
Sep 20, 2023 · AOH1996, a drug named in honor of Anna Olivia Healy, is being tested in a phase 1 trial. As nurses, we must help our patients understand that phase 1 trials represent very early research.
Treating Elderly Patients: How Old Is Too Old? - Oncology Nursing …
Mar 18, 2015 · Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN. Editor-in-Chief OncLive Nursing. Oncology Nursing Consultant, Adjunct Assistant Professor of NursingLouisiana State Health Sciences Center in New Orleans, Louisiana. The terminology of aging has changed over the past decade or so, and we’re now using phrases such as young old (aged 60 to 69 years), middle old (aged 70 to 79 years), and the ...
The Role of Advanced Practice Nursing in Palliative Care
Mar 27, 2014 · Katherine Yeager, PhD, RN. Research Assistant Professor. With the aging of the US population, the number of seriously ill patients with complex conditions is expected to rise.